齐达斯和阿尔凯姆在印度推出了价格实惠的血型胺注射剂,扩大糖尿病治疗及体重管理服务. Zydus and Alkem launch affordable semaglutide injections in India, expanding access to diabetes and weight management treatment.

齐达斯生命科学公司在印度推出了一种新的半胺注射剂,通过可重复使用的多剂量笔装置进行注射,为患者提供了方便的选择. Zydus Lifesciences has launched a new semaglutide injection in India, delivered via a reusable, multi-dose pen device, offering a convenient option for patients. 艾尔凯姆实验室也将推出自己的西马格卢提德注射剂, 每周治疗费用从450卢比起. This comes alongside Alkem Laboratories' entry into the market with its own semaglutide injection, priced at a weekly therapy cost starting at Rs 450. 两种药品的推出旨在增加印度糖尿病和体重管理药物的使用率. Both launches aim to increase access to this diabetes and weight management medication in India.